MedTrace Logo

Cardiovascular Safety After Continuous Ketamine Infusion

NCT03979105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-06-07

No results posted yet for this study

Summary

Observational study that evaluate the cardiovascular and neuropsychiatric side effects of ketamine analgesic infusions for acute pain

Conditions

  • Pain
  • Ketamine Adverse Reaction
  • Postoperative Pain

Interventions

DRUG

Ketamine

Drug: Ketamine Side effects associated with ketamine infusion to treat acute pain, were reviewed after 48 hours of exposure and frequency of tachycardia, hypertension, hallucinations, delirium and nightmares were registrated for comparison

Sponsors & Collaborators

  • Universidad de Antioquia

    lead OTHER

Principal Investigators

  • Adriana M Cadavid, MD · Anesthesiology Investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-11-01
Completion
2018-12-31

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03979105 on ClinicalTrials.gov